NL2000376C2 - Piperidinederivaten. - Google Patents

Piperidinederivaten. Download PDF

Info

Publication number
NL2000376C2
NL2000376C2 NL2000376A NL2000376A NL2000376C2 NL 2000376 C2 NL2000376 C2 NL 2000376C2 NL 2000376 A NL2000376 A NL 2000376A NL 2000376 A NL2000376 A NL 2000376A NL 2000376 C2 NL2000376 C2 NL 2000376C2
Authority
NL
Netherlands
Prior art keywords
pharmaceutically acceptable
group
compound
ylmethoxy
acceptable salt
Prior art date
Application number
NL2000376A
Other languages
English (en)
Dutch (nl)
Other versions
NL2000376A1 (nl
Inventor
Patrick Michael O'brien
Kimberly Suzanne Para
Scott Edward Lazerwith
Michelle Marie Bruendl
Keri Lynn Greene
Allen Jennings Rex
Joe Nahra
Susan Mary Kult Sheehan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL2000376A1 publication Critical patent/NL2000376A1/nl
Application granted granted Critical
Publication of NL2000376C2 publication Critical patent/NL2000376C2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL2000376A 2005-12-20 2006-12-15 Piperidinederivaten. NL2000376C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75184505P 2005-12-20 2005-12-20
US75184505 2005-12-20

Publications (2)

Publication Number Publication Date
NL2000376A1 NL2000376A1 (nl) 2007-06-21
NL2000376C2 true NL2000376C2 (nl) 2007-10-24

Family

ID=38015373

Family Applications (2)

Application Number Title Priority Date Filing Date
NL2000376A NL2000376C2 (nl) 2005-12-20 2006-12-15 Piperidinederivaten.
NL2000937A NL2000937C2 (nl) 2005-12-20 2007-10-15 Piperidinederivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL2000937A NL2000937C2 (nl) 2005-12-20 2007-10-15 Piperidinederivaten.

Country Status (12)

Country Link
US (1) US20070142389A1 (enExample)
EP (1) EP1966137A2 (enExample)
JP (1) JP2009520018A (enExample)
AR (1) AR058110A1 (enExample)
CA (1) CA2634172A1 (enExample)
DO (1) DOP2006000287A (enExample)
GT (1) GT200600516A (enExample)
NL (2) NL2000376C2 (enExample)
PE (1) PE20071005A1 (enExample)
TW (1) TW200732304A (enExample)
UY (1) UY30029A1 (enExample)
WO (1) WO2007072150A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010059393A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Serotonin receptor modulators
WO2010059390A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Modulators of serotonin receptor
EP2358676B1 (en) 2008-11-14 2012-10-10 Theravance, Inc. Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
EP2523945A1 (en) 2010-01-11 2012-11-21 Theravance, Inc. 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors
JP6055784B2 (ja) * 2012-01-31 2016-12-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 パロキセチン誘導体
JP6898310B2 (ja) * 2015-09-02 2021-07-07 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． ６員アザヘテロ環を含有するデルタ−オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法
US11702408B2 (en) 2017-02-17 2023-07-18 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
AU2018221705B2 (en) 2017-02-17 2022-10-27 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN111533682B (zh) * 2020-05-29 2022-03-01 清华大学 帕罗西汀及其类似物的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912743A (en) * 1973-01-30 1975-10-14 Ferrosan As 4-Phenylpiperidine compounds
EP0152273A2 (en) * 1984-02-07 1985-08-21 A/S Ferrosan A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use
EP0190496A2 (en) * 1984-12-13 1986-08-13 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
EP0266574A2 (en) * 1986-11-03 1988-05-11 Novo Nordisk A/S Piperidine compounds and their preparation and use
EP0339579A2 (en) * 1988-04-28 1989-11-02 Novo Nordisk A/S Piperidine compositions and their preparation and use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
US5227379A (en) * 1986-11-03 1993-07-13 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
IL98757A (en) * 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
US5808139A (en) * 1992-04-21 1998-09-15 Ligand Pharmaceuticals Incorporated Non-steroid progesterone receptor agonist and antagonist and compounds and methods
US5914328A (en) * 1992-10-09 1999-06-22 Abbott Laboratories Heterocyclic ether compounds useful in controlling neurotransmitter release
IL123293A (en) * 1995-09-07 2003-06-24 Hoffmann La Roche Piperidine derivatives, their preparation and pharmaceutical compositions containing them
US20020151712A1 (en) * 1999-09-14 2002-10-17 Nan-Horng Lin 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
WO2001032178A1 (en) * 1999-10-29 2001-05-10 Novo Nordisk A/S Use of 3,4-substituted piperidines
JP2004504319A (ja) * 2000-07-17 2004-02-12 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー ４−フェニルピペリジン誘導体の新規製造方法
WO2003014114A2 (en) * 2001-08-08 2003-02-20 Neurosearch A/S Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912743A (en) * 1973-01-30 1975-10-14 Ferrosan As 4-Phenylpiperidine compounds
EP0152273A2 (en) * 1984-02-07 1985-08-21 A/S Ferrosan A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use
EP0190496A2 (en) * 1984-12-13 1986-08-13 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
EP0266574A2 (en) * 1986-11-03 1988-05-11 Novo Nordisk A/S Piperidine compounds and their preparation and use
EP0339579A2 (en) * 1988-04-28 1989-11-02 Novo Nordisk A/S Piperidine compositions and their preparation and use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
P. PLENGE ET AL, J. PHARM. PHARMACOL., vol. 39, no. 11, 1987, pages 877 - 882, XP009022055 *
V.D. PATIL ET AL, INDIAN DRUGS, vol. 35, no. 11, 1998, pages 686 - 692, XP008079062 *

Also Published As

Publication number Publication date
UY30029A1 (es) 2007-07-31
DOP2006000287A (es) 2007-11-30
CA2634172A1 (en) 2007-06-28
WO2007072150A3 (en) 2008-05-29
NL2000937A1 (nl) 2008-01-11
EP1966137A2 (en) 2008-09-10
US20070142389A1 (en) 2007-06-21
GT200600516A (es) 2007-08-21
AR058110A1 (es) 2008-01-23
JP2009520018A (ja) 2009-05-21
WO2007072150A2 (en) 2007-06-28
NL2000376A1 (nl) 2007-06-21
NL2000937C2 (nl) 2008-07-22
TW200732304A (en) 2007-09-01
PE20071005A1 (es) 2007-10-24

Similar Documents

Publication Publication Date Title
US12264169B2 (en) Heteroaryl inhibitors of PDE4
NL2000937C2 (nl) Piperidinederivaten.
CN103038229B (zh) 杂芳基化合物及其使用方法
JP6339595B2 (ja) 炎症性障害の治療のための化合物及びその医薬組成物
CN107223125B (zh) sGC刺激剂
WO2017140778A1 (en) Sulfonylureas and related compounds and use of same
JP2012502104A (ja) 疾患の治療のためのヒスタミン受容体に対するアミノピリミジン阻害剤
ES2788449T3 (es) Inhibidores de GLS1 para tratar enfermedades
WO2011025006A1 (ja) Ｇｐｒ１１９作動薬
TW201022257A (en) 7-azaspiro[3.5]nonane-7-carboxamide compounds
JP6496246B2 (ja) アルドステロンシンターゼインヒビター関連用途としてのインドリン化合物
US20080293715A1 (en) Therapeutic Pyrazolo[3,4-b]Pyridines and Indazoles
US9890171B2 (en) Aldosterone synthase inhibitors
US20250136604A1 (en) Substituted pyrazolopyrimidinone compounds as pde2 inhibitors
JP2009507912A (ja) 治療用のピロリジン
KR20250130620A (ko) 치환된 테트라하이드로피롤로-피리디논 화합물 및 의학적 병태 치료에서의 이의 용도
CA3047408C (en) Substituted pyrazolopyrimidinone compounds as pde2 inhibitors
HK1116484A (en) Therapeutic pyrazolo[3,4-b] pyridines and indazoles

Legal Events

Date Code Title Description
AD1B A search report has been drawn up
PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20100701